These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10461841)

  • 1. Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens.
    Diarra MS; Malouin F; Jacques M
    Int J Antimicrob Agents; 1999 Aug; 12(3):229-37. PubMed ID: 10461841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postantibiotic effects and postantibiotic sub-MIC effects of erythromycin, roxithromycin, tilmicosin, and tylosin on Pasteurella multocida.
    Lim J; Yun H
    Int J Antimicrob Agents; 2001 Jun; 17(6):471-6. PubMed ID: 11397617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine.
    Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K
    J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of porcine respiratory pathogens to tilmicosin.
    DeRosa DC; Veenhuizen MF; Bade DJ; Shryock TR
    J Vet Diagn Invest; 2000 Nov; 12(6):541-6. PubMed ID: 11108454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
    Blondeau JM; Fitch SD
    PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro pharmacodynamics of gamithromycin against Mycoplasma mycoides subspecies mycoides Small Colony.
    Mitchell JD; Goh S; McKellar QA; McKeever DJ
    Vet J; 2013 Sep; 197(3):806-11. PubMed ID: 23810743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
    McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
    J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tilmicosin on chemotactic, phagocytic, and bactericidal activities of bovine and porcine alveolar macrophages.
    Brumbaugh GW; Herman JD; Clancy JS; Burden KI; Barry T; Simpson RB; López HS
    Am J Vet Res; 2002 Jan; 63(1):36-41. PubMed ID: 16206777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
    Shryock TR; Staples JM; DeRosa DC
    J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens.
    Norcia LJ; Silvia AM; Santoro SL; Retsema J; Letavic MA; Bronk BS; Lundy KM; Yang B; Evans NA; Hayashi SF
    J Antibiot (Tokyo); 2004 Apr; 57(4):280-8. PubMed ID: 15217193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the minimal inhibitory concentration of tilmicosin and oxytetracycline for bovine pneumonic Pasteurella haemolytica isolates.
    Hartman EG; Geryl J
    Vet Q; 1993 Dec; 15(4):184. PubMed ID: 8122359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine.
    Moore GM; Basson RP; Tonkinson LV
    Am J Vet Res; 1996 Feb; 57(2):224-8. PubMed ID: 8633813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs.
    Blackall PJ; Asakawa T; Graydon RJ; White M; Adamson M; Wade LK; Lowe LB
    Aust Vet J; 1995 Jan; 72(1):35-6. PubMed ID: 8787526
    [No Abstract]   [Full Text] [Related]  

  • 14. The minimum inhibitory concentration of tilmicosin and tylosin for mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks.
    Jordan FT; Horrocks BK
    Avian Dis; 1996; 40(2):326-34. PubMed ID: 8790882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use.
    Norcia LJ; Seibel SB; Kamicker BJ; Lemay MA; Lilley SC; Hecker SJ; Bergeron JM; Retsema JA; Hayashi SF
    J Antibiot (Tokyo); 1998 Feb; 51(2):136-44. PubMed ID: 9544934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease.
    Shryock TR; White DW; Staples JM; Werner CS
    J Vet Diagn Invest; 1996 Jul; 8(3):337-44. PubMed ID: 8844577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tilmicosin enteric granules and premix to pigs: Antimicrobial susceptibility testing and comparative pharmacokinetics.
    Xiong J; Zhu Q; Zhao Y; Yang S; Cao J; Qiu Y
    J Vet Pharmacol Ther; 2019 May; 42(3):336-345. PubMed ID: 30801755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae.
    Rose M; Menge M; Bohland C; Zschiesche E; Wilhelm C; Kilp S; Metz W; Allan M; Röpke R; Nürnberger M
    J Vet Pharmacol Ther; 2013 Apr; 36(2):140-53. PubMed ID: 22500881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Pasteurella haemolytica from cattle.
    Stephens CP; Blackall PJ; Wade LK; Lowe LB
    Aust Vet J; 1993 Oct; 70(10):391-2. PubMed ID: 8257321
    [No Abstract]   [Full Text] [Related]  

  • 20. Short communication: Interaction of the isomers carvacrol and thymol with the antibiotics doxycycline and tilmicosin: In vitro effects against pathogenic bacteria commonly found in the respiratory tract of calves.
    Kissels W; Wu X; Santos RR
    J Dairy Sci; 2017 Feb; 100(2):970-974. PubMed ID: 28012625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.